BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2323641)

  • 1. Magnetic resonance imaging follow-up in patients with acute leukemia during induction chemotherapy.
    Kusnierz-Glaz C; Reiser M; Hagemeister B; Büchner T; Hiddemann W; van de Loo J
    Haematol Blood Transfus; 1990; 33():351-6. PubMed ID: 2323641
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
    Petti MC; Avvisati G; Tafuri A; Meloni G; Amadori S; Mandelli F
    Ann N Y Acad Sci; 1987; 511():436-41. PubMed ID: 3326472
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring the remission induction therapy of acute nonlymphoblastic leukemia by bone marrow cell culture criteria.
    Bohinjec J; Zontar D; Kralj J
    Leuk Res; 1985; 9(3):369-73. PubMed ID: 3999798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone and cytarabine versus daunorubicin and cytarabine in previously untreated patients with acute myeloid leukemia.
    Wahlin A; Hörnsten P; Hedenus M; Malm C
    Cancer Chemother Pharmacol; 1991; 28(6):480-3. PubMed ID: 1934252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
    Schiller G; Gajewski J; Lee M; Ho W; Territo M; Champlin R
    Leuk Lymphoma; 1994 Sep; 15(1-2):85-90. PubMed ID: 7858506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK; Gray RG
    Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemia.
    Meckenstock G; Heyll A; Schneider EM; Hildebrandt B; Runde V; Aul C; Bartram CR; Ludwig WD; Schneider W
    Leukemia; 1995 Feb; 9(2):260-4. PubMed ID: 7869761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
    Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
    Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
    [No Abstract]   [Full Text] [Related]  

  • 10. Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report.
    Björkholm M; Killander A
    Eur J Haematol Suppl; 1987; 47():49-54. PubMed ID: 3471525
    [No Abstract]   [Full Text] [Related]  

  • 11. Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.
    Bern MM; Wallach SR; Arkin CF; Lokich JJ; Huberman MS; Anderson NR; Corkery JC; Paul SD; Phillips DF; Sonneborn HA
    Cancer Treat Rep; 1987 Feb; 71(2):201-3. PubMed ID: 3802115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.
    Büchner T; Berdel WE; Hiddemann W
    N Engl J Med; 2004 May; 350(21):2215-6. PubMed ID: 15152074
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute megakaryoblastic leukemia (FAB-M7) in an infant presenting with orbital chloroma and meningeal involvement.
    Suttorp M; Polchau H; Kühn B; Löffler H; Rister M
    Haematol Blood Transfus; 1990; 33():368-73. PubMed ID: 2323644
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
    Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
    Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
    Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
    J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult acute nonlymphocytic leukemia.
    Cassileth PA
    Med Clin North Am; 1984 May; 68(3):675-95. PubMed ID: 6379338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
    Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
    [No Abstract]   [Full Text] [Related]  

  • 18. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
    Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
    Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic study of cytosine arabinoside in patients with acute myelogeneous leukemia.
    Preusser P; Pielken HJ; Bauch HJ
    Haematol Blood Transfus; 1987; 30():288-92. PubMed ID: 3476359
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction chemotherapy for acute myelogenous leukemia.
    Kalaycio M
    Curr Hematol Rep; 2005 Jan; 4(1):49-50. PubMed ID: 15610659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.